Table of Content


Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data Sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Point of care testing industry 360 degree synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Technology trends
2.1.4 Prescription trends
2.1.5 Application trends
2.1.6 End-use trends
2.1.7 Regional trends
Chapter 3 Point of Care Testing Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Upward trend in disease prevalence among developing countries
3.3.1.2 Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America
3.3.1.3 Technological advancements
3.3.1.4 Increasing R&D investment
3.3.1.5 Growing geriatric population base globally
3.3.2 Industry pitfalls & challenges
3.3.2.1 Increasing R&D investment
3.3.2.2 High cost of product development
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By technology
3.4.3 By prescription
3.4.4 By application
3.4.5 By end-use
3.5 COVID-19 impact analysis
3.6 Pricing analysis, by cardiac markers, 2021
3.7 Regulatory landscape
3.8 Technology landscape
3.9 Company share analysis, 2021 (by region)
3.9.1 Global market share analysis, 2021
3.9.2 North America
3.9.3 Europe
3.9.4 Asia Pacific
3.9.5 Latin America
3.9.6 MEA
3.10 Porter’s analysis
3.11 Competitive landscape, 2021
3.11.1 Company matrix analysis, 2021
3.12 PESTEL analysis
Chapter 4 Point of Care Testing Market, By Product
4.1 Key segment trends
4.2 Glucose monitoring
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.2 Strips
4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.3 Meters
4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.4 Lancets
4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Cardiometabolic testing products
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.2 Cardiac marker testing products
4.3.2.1 Market size, by region, 2017-2030 (USD Million)
4.3.2.2 High sensitivity troponin I (hsTnI)
4.3.2.2.1 Market size, by region, 2017-2030 (USD Million)
4.3.2.3 Brain natriuretic peptide (BNP)
4.3.2.3.1 Market size, by region, 2017-2030 (USD Million)
4.3.2.4 D-dimer
4.3.2.4.1 Market size, by region, 2017-2030 (USD Million)
4.3.2.5 Creatine kinase-MB (CK-MB)
4.3.2.5.1 Market size, by region, 2017-2030 (USD Million)
4.3.2.6 Myoglobin
4.3.2.6.1 Market size, by region, 2017-2030 (USD Million)
4.3.2.7 Others
4.3.2.7.1 Market size, by region, 2017-2030 (USD Million)
4.3.3 Blood Gas/Electrolytes testing products
4.3.3.1 Market size, by region, 2017-2030 (USD Million)
4.3.4 HBA1C testing products
4.3.4.1 Market size, by region, 2017-2030 (USD Million)
4.4 Infectious disease testing products
4.4.1 Market size, by region, 2017-2030 (USD Million)
4.4.2 Influenza testing products
4.4.2.1 Market size, by region, 2017-2030 (USD Million)
4.4.3 HIV testing products
4.4.3.1 Market size, by region, 2017-2030 (USD Million)
4.4.4 Hepatitis C testing products
4.4.4.1 Market size, by region, 2017-2030 (USD Million)
4.4.5 Sexually transmitted disease (STD) testing products
4.4.5.1 Market size, by region, 2017-2030 (USD Million)
4.4.6 Healthcare-associated Infection (HAI) testing products
4.4.6.1 Market size, by region, 2017-2030 (USD Million)
4.4.7 Respiratory infection testing products
4.4.7.1 Market size, by region, 2017-2030 (USD Million)
4.4.8 Tropical disease testing products
4.4.8.1 Market size, by region, 2017-2030 (USD Million)
4.4.9 Other infectious diseases testing products
4.4.9.1 Market size, by region, 2017-2030 (USD Million)
4.5 Coagulation testing products
4.5.1 Market size, by region, 2017-2030 (USD Million)
4.5.2 PT/INR testing products
4.5.2.1 Market size, by region, 2017-2030 (USD Million)
4.5.3 Activated clotting time (ACT/APTT) testing products
4.5.3.1 Market size, by region, 2017-2030 (USD Million)
4.6 Pregnancy & fertility testing products
4.6.1 Market size, by region, 2017-2030 (USD Million)
4.6.2 Pregnancy testing products
4.6.2.1 Market size, by region, 2017-2030 (USD Million)
4.6.3 Fertility testing products
4.6.3.1 Market size, by region, 2017-2030 (USD Million)
4.7 Tumor/Cancer marker testing products
4.7.1 Market size, by region, 2017-2030 (USD Million)
4.8 Cholesterol testing products
4.8.1 Market size, by region, 2017-2030 (USD Million)
4.9 Hematology testing products
4.9.1 Market size, by region, 2017-2030 (USD Million)
4.10 Drug-of-Abuse (DoA) testing products
4.10.1 Market size, by region, 2017-2030 (USD Million)
4.11 Fecal occult testing products
4.11.1 Market size, by region, 2017-2030 (USD Million)
4.12 Urinalysis testing products
4.12.1 Market size, by region, 2017-2030 (USD Million)
4.13 Other products
4.13.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Point of Care Testing Market, By Technology
5.1 Key segment trends
5.2 Lateral flow assays
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Dipsticks
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Microfluidics
5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Molecular diagnostics
5.5.1 Market size, by region, 2017 - 2030 (USD Million)
5.6 Immunoassays
5.6.1 Market size, by region, 2017 - 2030 (USD Million)
5.7 Agglutination assays
5.7.1 Market size, by region, 2017 - 2030 (USD Million)
5.8 Flow-through
5.8.1 Market size, by region, 2017 - 2030 (USD Million)
5.9 Solid phase
5.9.1 Market size, by region, 2017 - 2030 (USD Million)
5.10 Biosensors
5.10.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Point of Care Testing Market, By Prescription
6.1 Key segment trends
6.2 OTC testing
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Prescription-based testing
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Point of Care Testing Market, By Application
7.1 Key segment trends
7.2 Cardio metabolic testing
7.2.1 Market size, by region, 2017 - 2030 (USD Million)
7.3 Infectious disease testing
7.3.1 Market size, by region, 2017 - 2030 (USD Million)
7.4 Nephrology testing
7.4.1 Market size, by region, 2017 - 2030 (USD Million)
7.5 Drug-of-Abuse (DoA) testing
7.5.1 Market size, by region, 2017 - 2030 (USD Million)
7.6 Blood glucose testing
7.6.1 Market size, by region, 2017 - 2030 (USD Million)
7.7 Pregnancy testing
7.7.1 Market size, by region, 2017 - 2030 (USD Million)
7.8 Cancer biomarker testing
7.8.1 Market size, by region, 2017 - 2030 (USD Million)
7.9 Other applications
7.9.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Point of Care Testing Market, By End-use
8.1 Key segment trends
8.2 Hospitals
8.2.1 Market size, by region, 2017 - 2030 (USD Million)
8.3 Diagnostic centers
8.3.1 Market size, by region, 2017 - 2030 (USD Million)
8.4 Research laboratories
8.4.1 Market size, by region, 2017 - 2030 (USD Million)
8.5 Home-care settings
8.5.1 Market size, by region, 2017 - 2030 (USD Million)
8.6 other
8.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 9 Point of Care Testing Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 Market size, by country, 2017 - 2030 (USD Million)
9.2.2 Market size, by product, 2017 - 2030 (USD Million)
9.2.2.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.2.2.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.2.2.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.2.2.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.2.2.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.2.2.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.2.3 Market size, by technology, 2017 - 2030 (USD Million)
9.2.4 Market size, by prescription, 2017 - 2030 (USD Million)
9.2.5 Market size, by application, 2017 - 2030 (USD Million)
9.2.6 Market size, by end-use, 2017 - 2030 (USD Million)
9.2.7 U.S.
9.2.7.1 Market size, by product, 2017 - 2030 (USD Million)
9.2.7.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.2.7.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.2.7.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.2.7.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.2.7.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.2.7.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.2.7.2 Market size, by technology, 2017 - 2030 (USD Million)
9.2.7.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.2.7.4 Market size, by application, 2017 - 2030 (USD Million)
9.2.7.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.2.8 Canada
9.2.8.1 Market size, by product, 2017 - 2030 (USD Million)
9.2.8.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.2.8.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.2.8.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.2.8.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.2.8.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.2.8.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.2.8.2 Market size, by technology, 2017 - 2030 (USD Million)
9.2.8.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.2.8.4 Market size, by application, 2017 - 2030 (USD Million)
9.2.8.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.3 Europe
9.3.1 Market size, by country, 2017 - 2030 (USD Million)
9.3.2 Market size, by product, 2017 - 2030 (USD Million)
9.3.2.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.3.2.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.3.2.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.3.2.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.3.2.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.3.2.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.3.3 Market size, by technology, 2017 - 2030 (USD Million)
9.3.4 Market size, by prescription, 2017 - 2030 (USD Million)
9.3.5 Market size, by application, 2017 - 2030 (USD Million)
9.3.6 Market size, by end-use, 2017 - 2030 (USD Million)
9.3.7 Germany
9.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
9.3.7.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.3.7.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.3.7.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.3.7.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.3.7.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.3.7.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.3.7.2 Market size, by technology, 2017 - 2030 (USD Million)
9.3.7.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.3.7.4 Market size, by application, 2017 - 2030 (USD Million)
9.3.7.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.3.8 UK
9.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
9.3.8.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.3.8.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.3.8.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.3.8.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.3.8.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.3.8.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.3.8.2 Market size, by technology, 2017 - 2030 (USD Million)
9.3.8.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.3.8.4 Market size, by application, 2017 - 2030 (USD Million)
9.3.8.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.3.9 France
9.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
9.3.9.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.3.9.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.3.9.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.3.9.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.3.9.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.3.9.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.3.9.2 Market size, by technology, 2017 - 2030 (USD Million)
9.3.9.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.3.9.4 Market size, by application, 2017 - 2030 (USD Million)
9.3.9.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.3.10 Spain
9.3.10.1 Market size, by product, 2017 - 2030 (USD Million)
9.3.10.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.3.10.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.3.10.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.3.10.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.3.10.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.3.10.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.3.10.2 Market size, by technology, 2017 - 2030 (USD Million)
9.3.10.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.3.10.4 Market size, by application, 2017 - 2030 (USD Million)
9.3.10.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.3.11 Italy
9.3.11.1 Market size, by product, 2017 - 2030 (USD Million)
9.3.11.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.3.11.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.3.11.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.3.11.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.3.11.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.3.11.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.3.11.2 Market size, by technology, 2017 - 2030 (USD Million)
9.3.11.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.3.11.4 Market size, by application, 2017 - 2030 (USD Million)
9.3.11.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Market size, by country, 2017 - 2030 (USD Million)
9.4.2 Market size, by product, 2017 - 2030 (USD Million)
9.4.2.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.4.2.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.4.2.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.4.2.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.4.2.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.4.2.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.4.3 Market size, by technology, 2017 - 2030 (USD Million)
9.4.4 Market size, by prescription, 2017 - 2030 (USD Million)
9.4.5 Market size, by application, 2017 - 2030 (USD Million)
9.4.6 Market size, by end-use, 2017 - 2030 (USD Million)
9.4.7 China
9.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
9.4.7.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.4.7.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.4.7.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.4.7.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.4.7.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.4.7.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.4.7.2 Market size, by technology, 2017 - 2030 (USD Million)
9.4.7.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.4.7.4 Market size, by application, 2017 - 2030 (USD Million)
9.4.7.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.4.8 India
9.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
9.4.8.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.4.8.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.4.8.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.4.8.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.4.8.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.4.8.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.4.8.2 Market size, by technology, 2017 - 2030 (USD Million)
9.4.8.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.4.8.4 Market size, by application, 2017 - 2030 (USD Million)
9.4.8.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.4.9 Japan
9.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
9.4.9.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.4.9.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.4.9.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.4.9.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.4.9.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.4.9.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.4.9.2 Market size, by technology, 2017 - 2030 (USD Million)
9.4.9.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.4.9.4 Market size, by application, 2017 - 2030 (USD Million)
9.4.9.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.4.10 Australia
9.4.10.1 Market size, by product, 2017 - 2030 (USD Million)
9.4.10.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.4.10.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.4.10.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.4.10.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.4.10.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.4.10.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.4.10.2 Market size, by technology, 2017 - 2030 (USD Million)
9.4.10.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.4.10.4 Market size, by application, 2017 - 2030 (USD Million)
9.4.10.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.5 Latin America
9.5.1 Market size, by country, 2017 - 2030 (USD Million)
9.5.2 Market size, by product, 2017 - 2030 (USD Million)
9.5.2.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.5.2.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.5.2.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.5.2.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.5.2.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.5.2.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.5.3 Market size, by technology, 2017 - 2030 (USD Million)
9.5.4 Market size, by prescription, 2017 - 2030 (USD Million)
9.5.5 Market size, by application, 2017 - 2030 (USD Million)
9.5.6 Market size, by end-use, 2017 - 2030 (USD Million)
9.5.7 Brazil
9.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
9.5.7.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.5.7.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.5.7.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.5.7.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.5.7.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.5.7.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.5.7.2 Market size, by technology, 2017 - 2030 (USD Million)
9.5.7.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.5.7.4 Market size, by application, 2017 - 2030 (USD Million)
9.5.7.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.5.8 Mexico
9.5.8.1 Market size, by product, 2017 - 2030 (USD Million)
9.5.8.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.5.8.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.5.8.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.5.8.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.5.8.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.5.8.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.5.8.2 Market size, by technology, 2017 - 2030 (USD Million)
9.5.8.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.5.8.4 Market size, by application, 2017 - 2030 (USD Million)
9.5.8.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.6 MEA
9.6.1 Market size, by country, 2017 - 2030 (USD Million)
9.6.2 Market size, by product, 2017 - 2030 (USD Million)
9.6.2.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.6.2.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.6.2.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.6.2.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.6.2.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.6.2.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.6.3 Market size, by technology, 2017 - 2030 (USD Million)
9.6.4 Market size, by prescription, 2017 - 2030 (USD Million)
9.6.5 Market size, by application, 2017 - 2030 (USD Million)
9.6.6 Market size, by end-use, 2017 - 2030 (USD Million)
9.6.7 South Africa
9.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
9.6.7.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.6.7.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.6.7.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.6.7.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.6.7.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.6.7.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.6.7.2 Market size, by technology, 2017 - 2030 (USD Million)
9.6.7.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.6.7.4 Market size, by application, 2017 - 2030 (USD Million)
9.6.7.5 Market size, by end-use, 2017 - 2030 (USD Million)
9.6.8 Saudi Arabia
9.6.8.1 Market size, by product, 2017 - 2030 (USD Million)
9.6.8.1.1 Market size, by glucose monitoring, 2017-2030 (USD Million)
9.6.8.1.2 Market size, by cardiometabolic testing products, 2017-2030 (USD Million)
9.6.8.1.2.1 Market size, by cardiac marker testing product, 2017-2030 (USD Million)
9.6.8.1.3 Market size, by infectious disease testing products, 2017-2030 (USD Million)
9.6.8.1.4 Market size, by coagulation testing products, 2017-2030 (USD Million)
9.6.8.1.5 Market size, by pregnancy & fertility testing products, 2017-2030 (USD Million)
9.6.8.2 Market size, by technology, 2017 - 2030 (USD Million)
9.6.8.3 Market size, by prescription, 2017 - 2030 (USD Million)
9.6.8.4 Market size, by application, 2017 - 2030 (USD Million)
9.6.8.5 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 10 Company Profiles
10.1 Competitive dashboard
10.2 Abaxis
10.2.1 Business overview
10.2.2 Financial data
10.2.3 Product landscape
10.2.4 Strategic outlook
10.2.5 SWOT analysis
10.3 Abbott
10.3.1 Business overview
10.3.2 Financial data
10.3.3 Product landscape
10.3.4 Strategic outlook
10.3.5 SWOT analysis
10.4 Accubiotech Co, Ltd.
10.4.1 Business overview
10.4.2 Financial data
10.4.3 Product landscape
10.4.4 Strategic outlook
10.4.5 SWOT analysis
10.5 ACON Laboratories, Inc
10.5.1 Business overview
10.5.2 Financial data
10.5.3 Product landscape
10.5.4 Strategic outlook
10.5.5 SWOT analysis
10.6 Becton, Dickinson and Company
10.6.1 Business overview
10.6.2 Financial data
10.6.3 Product landscape
10.6.4 Strategic outlook
10.6.5 SWOT analysis
10.7 bioLytical Laboratories Inc
10.7.1 Business overview
10.7.2 Financial data
10.7.3 Product landscape
10.7.4 Strategic outlook
10.7.5 SWOT analysis
10.8 BioMrieux SA
10.8.1 Business overview
10.8.2 Financial data
10.8.3 Product landscape
10.8.4 Strategic outlook
10.9 Bio-Rad Laboratories, Inc
10.9.1 Business overview
10.9.2 Financial data
10.9.3 Product landscape
10.9.4 Strategic outlook
10.9.5 SWOT analysis
10.10 HemoCue AB (Danaher Corporation)
10.10.1 Business overview
10.10.2 Financial data
10.10.3 Product landscape
10.10.4 Strategic outlook
10.10.5 SWOT analysis
10.11 Dexcom, Inc
10.11.1 Business overview
10.11.2 Financial data
10.11.3 Product landscape
10.11.4 Strategic outlook
10.11.5 SWOT analysis
10.12 Dragerwerk Ag & Co
10.12.1 Business overview
10.12.2 Financial data
10.12.3 Product landscape
10.12.4 Strategic outlook
10.12.5 SWOT analysis
10.13 LifeScan IP Holding